Enlivex Therapeutics Ltd. ( ENLV) - Stock Earnings
ENLV Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 13, 2026, midnight | — / — | — | — / — | — |
ENLV Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 1.2 billion USD | — USD |
| 2026Q1 | 974.5 million USD | — USD |
| 2026Q2 | 1.9 billion USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ENLV Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -29.1 million USD | — USD |
| 2024 | -15.0 million USD | — USD |
| 2025 | 1.2 billion USD | — USD |
| 2026 Est. | — | — |
ENLV
Price: $1.44
52 week price:
Earnings Per Share: 415.39 USD
P/E Ratio: 0.00
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 21300
Market Capitalization: 23.7 million